A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Invasive Breast Cancer
Interventions: DRUG: doxorubicin|DRUG: cyclophosphamide|DRUG: paclitaxel|DRUG: trastuzumab|DRUG: lapatinib
Sponsor: NSABP Foundation Inc
Collaborators: GlaxoSmithKline